Loading...
compliance

Pyxis Override Audit

Audit automated dispensing cabinet overrides to spot unsafe patterns, verify clinical justification, and document pharmacy follow-up before issues become repeat non-conformances.

Trusted by frontline teams 15 years of frontline software AI customization in seconds

Built for: Hospitals · Ambulatory Surgery Centers · Long Term Care · Emergency Departments

Overview

This Pyxis Override Audit template is used to review automated dispensing cabinet overrides and determine whether they were clinically justified, properly documented, and followed by pharmacy review. It walks the reviewer through audit identification, override frequency and pattern review, reason and clinical justification, pharmacy follow-up, and risk escalation so the final record shows both what happened and what action was taken.

Use this template when you need to monitor override behavior by location, unit, cabinet, shift, or user and compare the current period against prior audits. It is especially useful when override volume is rising, when the same users or prescribers appear repeatedly, or when high-alert medications and controlled substances are involved. The template helps distinguish urgent, time-sensitive access from convenience-based workarounds that can create patient safety risk.

Do not use this as a generic medication administration checklist or as a replacement for order verification. It is not meant for routine dispensing that follows normal workflow, and it should not be used to judge a single override in isolation without context. The strongest value comes from trend review, documented pharmacy follow-up, and clear escalation when repeat non-conformance or diversion concern is identified.

Standards & compliance context

  • This template supports medication-use oversight expected in hospital pharmacy quality programs and accreditation-driven audit trails.
  • It helps document adherence to internal override policy, controlled substance controls, and escalation practices commonly reviewed under healthcare compliance programs.
  • When overrides involve high-alert medications, the review supports the stronger documentation and follow-up expectations associated with medication safety standards.
  • If diversion is suspected, the audit record should preserve objective facts for pharmacy leadership, compliance, and security review.
  • The template is compatible with broader patient safety and quality management systems that require traceable non-conformance review and corrective action tracking.

General regulatory context for orientation only — verify current requirements with counsel or the relevant agency before relying on this template for compliance.

What's inside this template

Audit Identification

This section establishes the audit’s scope and makes the review traceable to a specific period, location, and policy basis.

  • Audit period documented (weight 2.0)
    Record the start and end dates for the override audit period.
  • Location, unit, or cabinet identified (weight 2.0)
    Document the Pyxis/ADC location, unit, or cabinet reviewed.
  • Reviewer name and role documented (weight 2.0)
    Enter the name and role/title of the auditor or reviewer.
  • Review scope defined (weight 2.0)
    Select the scope of the audit review.
  • Reference policy or SOP documented (weight 2.0)
    List the policy, SOP, or medication management standard used for the review.

Override Frequency and Pattern Review

This section shows whether overrides are isolated events or part of a repeat pattern that needs action.

  • Override rate reviewed against expected use (weight 5.0)
    Enter the override count or rate for the audit period and compare it to expected operational use.
  • High-frequency override pattern identified (critical · weight 5.0)
    Determine whether the unit, shift, medication, or user shows repeated override activity that warrants follow-up.
  • Overrides concentrated during specific shift or time window (weight 5.0)
    Assess whether overrides cluster during nights, weekends, admissions surges, or other predictable periods.
  • Repeat override users or prescribers identified (weight 5.0)
    Identify whether the same staff members, prescribers, or care areas are associated with repeated overrides.
  • Trend compared with prior audit period (weight 5.0)
    Select the direction of change compared with the prior review period.

Override Reason and Clinical Justification

This section tests whether each override was truly urgent and clinically defensible rather than a convenience-based workaround.

  • Reason for override documented in dispensing record (critical · weight 5.0)
    Confirm that a reason for each reviewed override is documented in the ADC or associated medication record.
  • Reason aligns with urgent or time-sensitive clinical need (critical · weight 5.0)
    Assess whether the override was justified by urgent care needs, emergent treatment, or another approved exception.
  • Non-urgent or convenience-based override identified (critical · weight 5.0)
    Identify overrides that appear to bypass standard verification without a documented urgent clinical need.
  • Override reason category (weight 5.0)
    Select all applicable reason categories for the reviewed overrides.
  • High-alert medication or controlled substance involved (critical · weight 5.0)
    Indicate whether any reviewed override involved a high-alert medication, controlled substance, or other restricted item.

Pharmacy Follow-Up and Documentation

This section confirms that pharmacy reviewed the override, resolved discrepancies, and documented the outcome.

  • Pharmacy review completed for reviewed overrides (critical · weight 5.0)
    Confirm that pharmacy reviewed the override events within the expected follow-up timeframe.
  • Medication order entered or verified after override (weight 5.0)
    Confirm that a corresponding medication order was entered, verified, or reconciled after the override as applicable.
  • Discrepancies or undocumented doses investigated (critical · weight 5.0)
    Determine whether any mismatches between override removal and order verification were investigated and resolved.
  • Follow-up action documented (weight 5.0)
    Select all follow-up actions taken by pharmacy, leadership, or the unit.
  • Corrective action owner and due date assigned (weight 5.0)
    Document the responsible owner and target completion date for any corrective action.

Risk, Compliance, and Escalation

This section captures patient safety risk, repeat non-conformance, and the point where escalation is required.

  • Potential patient safety risk identified (critical · weight 4.0)
    Assess whether the override pattern suggests a patient safety risk, delay in care, or medication-use process failure.
  • Repeat non-conformance requires escalation (critical · weight 4.0)
    Determine whether repeated override issues require escalation to pharmacy leadership, nursing leadership, or the medication safety committee.
  • Controlled substance or diversion concern escalated (critical · weight 4.0)
    Indicate whether any override pattern raised concern for diversion, unauthorized access, or controlled substance handling issues.
  • Overall audit conclusion (weight 3.0)
    Select the overall result of the audit review.

How to use this template

  1. 1. Define the audit period, cabinet or unit scope, reviewer name, and the policy or SOP that governs overrides before you start the review.
  2. 2. Pull the override report for the selected period and sort it by time, user, medication, and cabinet so patterns are visible.
  3. 3. Check each reviewed override for documented clinical reason, order status, and whether the reason matches an urgent or time-sensitive need.
  4. 4. Record pharmacy follow-up actions, note any discrepancies or undocumented doses, and assign an owner and due date for corrective action.
  5. 5. Compare the current results with the prior audit period, flag repeat non-conformance or diversion concern, and document the overall conclusion and escalation path.

Best practices

  • Review overrides by shift and cabinet, not only in aggregate, so hidden workflow problems are easier to see.
  • Flag high-alert medications and controlled substances separately because they carry a higher patient safety and diversion risk.
  • Treat convenience-based reasons as a non-conformance even when the dose was ultimately administered.
  • Verify that the medication order was entered or confirmed after the override and not left as an undocumented dose.
  • Document the exact follow-up action, owner, and due date so the audit leads to closure instead of another review cycle.
  • Compare repeat users and repeat prescribers across periods to identify training gaps or process workarounds.
  • Escalate unresolved discrepancies promptly when the override pattern suggests a policy failure rather than an isolated event.

What this template typically catches

Issues teams running this template most often surface in practice:

Overrides used for medications that should have been ordered and verified before access.
Missing or vague clinical justification such as 'needed now' without a time-sensitive reason.
Repeated overrides by the same user, prescriber, unit, or cabinet during the same shift window.
Pharmacy follow-up not completed or not documented after the override review.
Undocumented doses or order discrepancies discovered after cabinet access.
High-alert medication overrides that were not escalated despite elevated risk.
Controlled substance overrides with weak traceability or unresolved count discrepancies.
Corrective actions assigned without a clear owner or due date.

Common use cases

Emergency Department Pharmacy Lead
Use this template to review frequent ED overrides where treatment urgency is real but documentation can drift. It helps separate legitimate emergent access from repeated workarounds that need workflow correction.
Inpatient Med-Surg Medication Safety Reviewer
Use this audit to compare override patterns across units and identify whether one floor is relying on cabinet access more than policy allows. It is useful for spotting repeat users, repeat prescribers, and delayed pharmacy verification.
Controlled Substance Compliance Coordinator
Use the template when overrides involve controlled substances or unexplained discrepancies. The escalation section helps route concerns to the right owner without losing the original audit trail.
Pharmacy Quality Manager
Use this as a recurring quality review tool to track trends over time and confirm that corrective actions were completed. It is especially helpful when you need a standardized record for leadership review.

Frequently asked questions

What does this Pyxis Override Audit template cover?

This template covers a review of automated dispensing cabinet overrides, including frequency, timing, repeat users, reason codes, pharmacy verification, and escalation. It is designed to show whether overrides were clinically justified and whether follow-up actions were completed. The output is an audit record that can support pharmacy quality review and patient safety monitoring.

How often should this audit be run?

Most organizations run it on a recurring cadence such as weekly, monthly, or per unit based on override volume and risk. High-risk areas, such as emergency departments or units with frequent controlled substance activity, may need a tighter review cycle. The right frequency is the one that lets pharmacy catch patterns before they become normalized workarounds.

Who should complete the audit?

A pharmacist, pharmacy leader, medication safety officer, or designated compliance reviewer usually completes it. The reviewer should understand dispensing workflows, order verification timing, and the organization’s override policy. If the audit is used for escalation, the reviewer should also know who owns corrective actions and follow-up.

Is this template tied to a specific regulation?

It is not limited to one citation, but it supports medication-use controls expected under healthcare accreditation and medication safety programs. It aligns with common expectations from pharmacy quality standards, controlled substance oversight, and internal policy governance. If your organization has a formal override policy, this audit helps document whether practice matches that policy.

What are the most common problems this audit finds?

Common findings include frequent overrides for medications that should have been ordered and verified first, undocumented clinical reasons, and repeat overrides by the same user or on the same cabinet. It also often surfaces delayed pharmacy follow-up, missing documentation of discrepancy resolution, and overrides involving high-alert medications that deserve escalation. Those patterns are useful because they point to workflow gaps, not just isolated events.

Can this template be customized for different units or cabinets?

Yes. You can tailor the review scope by location, unit type, cabinet name, medication class, or shift window. Many teams also add fields for controlled substances, high-alert medications, or specific prescriber groups so the audit matches local risk.

What should count as a valid override reason?

A valid reason should reflect an urgent or time-sensitive clinical need, such as immediate treatment before an order can be verified. Convenience, routine stock access, or workarounds for delayed ordering should not be treated as acceptable justification. The template helps separate true clinical urgency from process drift.

How does this compare with ad hoc override review?

Ad hoc review is useful for one-off incidents, but it usually misses repeat patterns and makes trend tracking difficult. This template standardizes the same checks each time, so pharmacy can compare periods, identify recurring users or shifts, and assign corrective actions consistently. That makes the review easier to defend and easier to act on.

Can this audit support controlled substance or diversion review?

Yes, especially when overrides involve controlled substances, discrepancies, or doses that were not followed by a verified order. The template includes escalation prompts so suspicious patterns can be routed to the right pharmacy, compliance, or security owner. It should be used as a review tool, not as a standalone diversion investigation record.

Ready to use this template?

Get started with MangoApps and use Pyxis Override Audit with your team — pricing built for small business.

Ask AI Product Advisor

Hi! I'm the MangoApps Product Advisor. I can help you with:

  • Understanding our 40+ workplace apps
  • Finding the right solution for your needs
  • Answering questions about pricing and features
  • Pointing you to free tools you can try right now

What would you like to know?